Arthritis drug may help severely ill COVID-19 patients if given early, study finds

(By Erica Carbajal for Becker’s Hospital Review)

Tocilizumab, a drug used to treat rheumatoid arthritis, may help reduce mortality in critically ill COVID-19 patients if given within the first two days of admission to an intensive care unit, according to a study published in JAMA Internal Medicine.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org